[go: up one dir, main page]

CN117599012A - Preparation method of nose comfort tablet - Google Patents

Preparation method of nose comfort tablet Download PDF

Info

Publication number
CN117599012A
CN117599012A CN202311682556.9A CN202311682556A CN117599012A CN 117599012 A CN117599012 A CN 117599012A CN 202311682556 A CN202311682556 A CN 202311682556A CN 117599012 A CN117599012 A CN 117599012A
Authority
CN
China
Prior art keywords
powder
cum bile
arisaema cum
mixing
weighed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202311682556.9A
Other languages
Chinese (zh)
Other versions
CN117599012B (en
Inventor
李治尧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi Ditai Pharmaceutical Co ltd
Original Assignee
Guangxi Ditai Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi Ditai Pharmaceutical Co ltd filed Critical Guangxi Ditai Pharmaceutical Co ltd
Priority to CN202311682556.9A priority Critical patent/CN117599012B/en
Publication of CN117599012A publication Critical patent/CN117599012A/en
Application granted granted Critical
Publication of CN117599012B publication Critical patent/CN117599012B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884Arisaema, e.g. Jack in the pulpit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a preparation method of a nose comfort tablet, which comprises the following steps: mixing fructus Xanthii, flos Chrysanthemi Indici, herba Centipedae, radix Angelicae Dahuricae, radix Saposhnikoviae, herba Ecliptae, radix Paeoniae alba, glycyrrhrizae radix and fructus Tribuli, pulverizing, micronizing to obtain second powder, mixing with water, extracting in a microwave and ultrasonic synergistic extraction tank, filtering, and concentrating to obtain soft extract; adding Arisaema cum bile fine powder and medicinal starch, granulating, drying, adding chlorpheniramine maleate, magnesium stearate, oleum herba Pogostemonis, and oleum Menthae Dementholatum, tabletting, and sugar coating. The preparation method adopts superfine grinding to treat the raw materials, and combines microwave-ultrasonic synergistic extraction to facilitate the full dissolution of active ingredients, avoid the damage of high temperature to the active ingredients, and the prepared nasal comfort tablet has high curative effect. Moreover, the method is simple to operate, is suitable for quality control, is convenient for industrial production, and has good application prospect.

Description

一种鼻舒适片的制备方法Preparation method of nasal comfort tablets

技术领域Technical field

本发明属于医药技术领域,具体涉及一种鼻舒适片的制备方法。The invention belongs to the field of medical technology, and specifically relates to a preparation method of nasal comfort tablets.

背景技术Background technique

据报告显示,全球有六分之一的人患有各种鼻炎,国内的鼻炎发病率远远高于这个数据。鼻炎是一种常见疾病,鼻炎即鼻腔炎性疾病,是病毒、细菌、变应原、各种理化因子以及某些全身性疾病引起的鼻腔黏膜的炎症,鼻炎的主要病理改变是鼻腔黏膜充血、肿胀、渗出、增生、萎缩或坏死等,尤其是在环境污染越来越严重,变化无常的极端天气愈来愈多的今天,鼻炎患者越来越多,且趋向低龄化,鼻炎看似小病实则危害很大,它在发病时期使人体五官受到极大的影响,给鼻炎患者工作、生活带来极大的痛苦,长期得不到有效治疗还会诱发多种严重疾病,甚至会危及生命。According to reports, one in six people worldwide suffers from various rhinitis, and the incidence of rhinitis in China is much higher than this figure. Rhinitis is a common disease. Rhinitis is an inflammatory disease of the nasal cavity. It is an inflammation of the nasal mucosa caused by viruses, bacteria, allergens, various physical and chemical factors, and certain systemic diseases. The main pathological changes of rhinitis are nasal mucosal congestion, Swelling, exudation, hyperplasia, atrophy or necrosis, etc. Especially today, when environmental pollution is becoming more and more serious and there are more and more unpredictable and extreme weather conditions, there are more and more rhinitis patients, and they tend to be younger, and rhinitis seems to be minor. The disease is actually very harmful. It greatly affects the five senses of the human body during the onset period and brings great pain to the work and life of rhinitis patients. If it is not effectively treated for a long time, it will induce a variety of serious diseases and even be life-threatening. .

而鼻舒适片收藏于卫生部药品标准中药成方制剂第七册。由苍耳子、野菊花、鹅不食草、白芷、防风、墨早莲、白芍、胆南星、甘草、蒺藜、马来酸氯苯那敏作为原料药制成。鼻舒适片具有清热消炎,通窍的功效,用于治疗慢性鼻炎引起的喷嚏、流涕、鼻塞、头痛,过敏性鼻炎,慢性鼻窦炎。且使用方便,具有极为广阔的市场销售前景。The Nasal Comfort Tablets are collected in the seventh volume of the Ministry of Health’s Drug Standards for Traditional Chinese Medicine Preparations. It is made from Xanthium sibiricum, wild chrysanthemum, gooseberry, angelica dahurica, sapsroot, moxa lotus, white peony root, binanxing, licorice, tribulus terrestris and chlorpheniramine maleate as raw materials. Nose Comfort Tablets have the effects of clearing away heat, reducing inflammation, and clearing the orifice. It is used to treat sneezing, runny nose, nasal congestion, headache caused by chronic rhinitis, allergic rhinitis, and chronic sinusitis. It is easy to use and has extremely broad market sales prospects.

但是,目前鼻舒适片的生产工艺有很多,导致鼻舒适片的品质参差不齐,另外,采用传统工艺制备,存在疗效低等不足。因此,有必要对鼻舒适片的制备方法进行改进。However, there are currently many production processes for nasal comfort tablets, resulting in uneven quality of nasal comfort tablets. In addition, the use of traditional processes to prepare nasal comfort tablets has shortcomings such as low efficacy. Therefore, it is necessary to improve the preparation method of nasal comfort tablets.

发明内容Contents of the invention

鉴于现有技术的不足,本发明所要解决的技术问题是提供一种鼻舒适片的制备方法,该方法采用超微粉碎来处理原料,结合微波-超声协同提取,利于活性成分的充分溶出,而且避免了高温对活性成分的破坏,制备的鼻舒适片具有高的疗效。In view of the shortcomings of the existing technology, the technical problem to be solved by the present invention is to provide a preparation method for nasal comfort tablets. This method uses ultrafine pulverization to process the raw materials, combined with microwave-ultrasonic collaborative extraction, which is conducive to the full dissolution of the active ingredients, and The destruction of active ingredients by high temperature is avoided, and the prepared nasal comfort tablets have high curative effect.

为达到本发明的目的,本发明采用了如下技术方案:In order to achieve the purpose of the present invention, the present invention adopts the following technical solutions:

本发明提供了一种鼻舒适片的制备方法,所述方法包括:The invention provides a method for preparing nasal comfort tablets, which method includes:

(1)称取苍耳子364g、野菊花145g、鹅不食草218g、白芷109g、防风109g、墨早莲218g、白芍145g、胆南星70g、甘草73g、蒺藜218g、马来酸氯苯那敏0.3g,备用;(1) Weigh 364g of Xanthium sibiricum, 145g of wild chrysanthemum, 218g of Herbivorous Goose, 109g of Angelica dahurica, 109g of Fangfeng, 218g of Asparagus chinensis, 145g of white peony root, 70g of Dannanxing, 73g of licorice, 218g of Tribulus terrestris, and chlorobenzene maleate. Namin 0.3g, spare;

(2)将步骤(1)称取的胆南星粉碎,过80-100目筛,得到胆南星细粉;(2) Crush the Dananxing weighed in step (1) and pass it through a 80-100 mesh sieve to obtain Dananxing fine powder;

(3)将步骤(1)称取的苍耳子、野菊花、鹅不食草、白芷、防风、墨早莲、白芍、甘草、蒺藜混合,然后采用粉碎机粉碎1h-2h后得到第一粉体,再将所述第一粉体置于超微粉碎机粉碎0.5-1h,制得第二粉体;(3) Mix the Xanthium angustifolia, wild chrysanthemum, geese, angelica dahurica, sapsroot, moxa lotus, white peony root, licorice, and tribulus terrestris weighed in step (1), and then use a grinder to crush them for 1h-2h to obtain the first A powder, and then grind the first powder in an ultrafine pulverizer for 0.5-1h to prepare a second powder;

(4)在步骤(3)制得的第二粉体中加入水混合,然后加入微波和超声波协同提取罐中进行提取,提取液经过滤、浓缩,得稠膏;(4) Add water to the second powder prepared in step (3) to mix, and then add microwave and ultrasonic waves to a cooperative extraction tank for extraction. The extract is filtered and concentrated to obtain a thick paste;

(5)将步骤(4)制得的稠膏中加入步骤(2)的胆南星细粉,再加入适量辅料药用淀粉,混匀,制成颗粒,干燥后再加入步骤(1)称取的马来酸氯苯那敏及适量硬脂酸镁、藿香油、薄荷油,混匀,经压片,包糖衣,即得鼻舒适片。(5) Add the binanxin fine powder from step (2) to the thick paste prepared in step (4), and then add an appropriate amount of auxiliary medicinal starch, mix well, and make granules. After drying, add the powder from step (1) and weigh Mix chlorpheniramine maleate with an appropriate amount of magnesium stearate, patchouli oil, and peppermint oil, press into tablets, and coat with sugar to obtain nasal comfort tablets.

优选的,步骤(4)中:Preferably, in step (4):

所述第二粉体与水的体积比为1:4-6。The volume ratio of the second powder to water is 1:4-6.

所述超声波频率为30-40KHz,功率为0.8-1KW;所述微波频率为1500-1600MHz,功率为2-2.5KW;所述协同提取温度为55-65℃,提取时间为1.5-2.5h。The ultrasonic frequency is 30-40KHz and the power is 0.8-1KW; the microwave frequency is 1500-1600MHz and the power is 2-2.5KW; the collaborative extraction temperature is 55-65°C and the extraction time is 1.5-2.5h.

所述浓缩采用真空浓缩罐,浓缩过程中,控制真空度0.04~0.06Mpa。The concentration uses a vacuum concentration tank. During the concentration process, the vacuum degree is controlled to 0.04-0.06Mpa.

优选的,步骤(5)中:Preferably, in step (5):

将步骤(4)制得的稠膏中加入步骤(2)的胆南星细粉,再加入适量辅料药用淀粉,在槽型混合机中混匀,再放入摇摆式颗粒机过12目筛制湿颗粒,然后放入一步制粒机干燥30~45分钟,控制温度在50~60℃使颗粒水分控制在5%以内,停止干燥,倾出,放入摇摆式颗粒机过14目筛整粒,最后将制得的颗粒投入总混设备中,加入步骤(1)称取的马来酸氯苯那敏及适量硬脂酸镁、藿香油、薄荷油,混匀,经压片,包糖衣,即得鼻舒适片。Add the Dannanxing fine powder from step (2) to the thick paste prepared in step (4), then add an appropriate amount of auxiliary medicinal starch, mix in a trough mixer, and then put it into a swing granulator to pass through a 12-mesh sieve. Wet the granules, and then put them into a one-step granulator to dry for 30 to 45 minutes. Control the temperature at 50 to 60°C to control the moisture content of the granules within 5%. Stop drying, pour out, and put them into a swing granulator to pass through a 14-mesh sieve. Granules, and finally put the prepared granules into the mixing equipment, add the chlorpheniramine maleate weighed in step (1) and an appropriate amount of magnesium stearate, patchouli oil, and peppermint oil, mix well, press into tablets, and wrap Sugar coating, you get nasal comfort tablets.

本发明相对于现有技术,具有以下有益效果:Compared with the existing technology, the present invention has the following beneficial effects:

本发明提供了一种鼻舒适片的制备方法,该方法采用超微粉碎来处理原料,再结合微波-超声协同提取,有利于活性成分的充分溶出,而且避免了高温对活性成分的破坏,制备的鼻舒适片具有高的疗效,由此可以减少口服用药量,降低了口服药物对人体肝脏的副作用。而且,该方法操作简单,适于质量把控,便于工业化生产,具有较好的应用前景。The invention provides a method for preparing nasal comfort tablets. The method uses ultrafine pulverization to process the raw materials, and then combines microwave-ultrasonic collaborative extraction, which is beneficial to the full dissolution of the active ingredients and avoids damage to the active ingredients at high temperatures. The preparation method The nasal comfort tablets have high efficacy, which can reduce the amount of oral medication and reduce the side effects of oral medications on the human liver. Moreover, this method is simple to operate, suitable for quality control, convenient for industrial production, and has good application prospects.

具体实施方式Detailed ways

下面详细描述本发明的实施例,所举实施例是为了更好地对本发明的内容进行说明,仅用于解释本发明,而不能理解为对本发明的限制。The embodiments of the present invention are described in detail below. The examples are given to better illustrate the content of the present invention. They are only used to explain the present invention and cannot be understood as limiting the present invention.

实施例中未注明具体技术或条件者,按照本领域内的文献所描述的技术或条件,或者按照产品说明书进行。所用试剂或仪器未注明生产厂商者,均为可通过正规渠道购买得到的常规产品。If specific techniques or conditions are not specified in the examples, the techniques or conditions described in literature in the field shall be followed, or the product instructions shall be followed. If the manufacturer of the reagents or instruments used is not indicated, they are all conventional products that can be purchased through regular channels.

实施例1:鼻舒适片的制备方法,包括:Example 1: Preparation method of nasal comfort tablets, including:

(1)称取苍耳子364g、野菊花145g、鹅不食草218g、白芷109g、防风109g、墨早莲218g、白芍145g、胆南星70g、甘草73g、蒺藜218g、马来酸氯苯那敏0.3g;(1) Weigh 364g of Xanthium sibiricum, 145g of wild chrysanthemum, 218g of Herbivorous Goose, 109g of Angelica dahurica, 109g of Fangfeng, 218g of Asparagus chinensis, 145g of white peony root, 70g of Dannanxing, 73g of licorice, 218g of Tribulus terrestris, and chlorobenzene maleate. Namin 0.3g;

(2)将步骤(1)称取的胆南星粉碎,过80目筛,得到胆南星细粉;(2) Crush the Dananxing weighed in step (1) and pass it through an 80-mesh sieve to obtain Dananxing fine powder;

(3)将步骤(1)称取的苍耳子、野菊花、鹅不食草、白芷、防风、墨早莲、白芍、甘草、蒺藜混合,然后采用粉碎机粉碎1h后得到第一粉体,再将所述第一粉体置于超微粉碎机粉碎0.5h,制得第二粉体;(3) Mix the Xanthium angustifolia, wild chrysanthemum, geese, angelica dahurica, saspermum, moxibustion root, white peony root, licorice, and tribulus terrestris weighed in step (1), and then use a grinder to crush it for 1 hour to obtain the first powder body, and then pulverize the first powder in an ultrafine pulverizer for 0.5h to obtain a second powder;

(4)在步骤(3)制得的第二粉体中加入4倍其体积的水,搅拌混合,然后加入微波和超声波协同提取罐中进行提取,超声波频率为30KHz,功率为0.8KW;微波频率为1500MHz,功率为2KW;协同提取温度为55℃,提取时间为1.5h;所得提取液经过滤、滤液采用真空浓缩罐浓缩,控制真空度为0.04Mpa,待提取液浓缩至密度1.30~1.35时,制得稠膏;(4) Add 4 times the volume of water to the second powder prepared in step (3), stir and mix, and then add microwave and ultrasonic waves to a cooperative extraction tank for extraction. The ultrasonic frequency is 30KHz and the power is 0.8KW; microwave The frequency is 1500MHz, the power is 2KW; the collaborative extraction temperature is 55°C, and the extraction time is 1.5h; the obtained extract is filtered, and the filtrate is concentrated using a vacuum concentration tank. The vacuum degree is controlled to 0.04Mpa, and the extract is concentrated to a density of 1.30~1.35 When, a thick paste is made;

(5)将步骤(4)制得的稠膏中加入步骤(2)的胆南星细粉,再加入适量辅料药用淀粉,在槽型混合机中混匀,再放入摇摆式颗粒机过12目筛制湿颗粒,然后放入一步制粒机干燥30分钟,控制温度在50℃使颗粒水分控制在5%以内,停止干燥,倾出,放入摇摆式颗粒机过14目筛整粒,最后将制得的颗粒投入总混设备中,加入步骤(1)称取的马来酸氯苯那敏及适量硬脂酸镁、0.5ml藿香油、0.5ml薄荷油,混匀,经压片,包糖衣,即得鼻舒适片1000片(每片0.2g)。(5) Add the Dannanxing fine powder from step (2) to the thick paste prepared in step (4), then add an appropriate amount of auxiliary medicinal starch, mix in a trough mixer, and then put it into a swing granulator to pass Make wet granules through a 12-mesh sieve, and then put them into a one-step granulator to dry for 30 minutes. Control the temperature at 50°C to control the moisture content of the granules within 5%. Stop drying, pour out, and put them into a swing granulator through a 14-mesh sieve for granulation. , finally put the prepared granules into the general mixing equipment, add the chlorpheniramine maleate weighed in step (1) and an appropriate amount of magnesium stearate, 0.5ml patchouli oil, 0.5ml peppermint oil, mix well, and press Tablets, sugar-coated, to obtain 1,000 nasal comfort tablets (0.2g each).

实施例2:鼻舒适片的制备方法,包括:Example 2: Preparation method of nasal comfort tablets, including:

(1)称取苍耳子364g、野菊花145g、鹅不食草218g、白芷109g、防风109g、墨早莲218g、白芍145g、胆南星70g、甘草73g、蒺藜218g、马来酸氯苯那敏0.3g;(1) Weigh 364g of Xanthium sibiricum, 145g of wild chrysanthemum, 218g of Herbivorous Goose, 109g of Angelica dahurica, 109g of Fangfeng, 218g of Asparagus chinensis, 145g of white peony root, 70g of Dannanxing, 73g of licorice, 218g of Tribulus terrestris, and chlorobenzene maleate. Namin 0.3g;

(2)将步骤(1)称取的胆南星粉碎,过100目筛,得到胆南星细粉;(2) Crush the Dananxing weighed in step (1) and pass it through a 100-mesh sieve to obtain Dananxing fine powder;

(3)将步骤(1)称取的苍耳子、野菊花、鹅不食草、白芷、防风、墨早莲、白芍、甘草、蒺藜混合,然后采用粉碎机粉碎2h后得到第一粉体,再将所述第一粉体置于超微粉碎机粉碎1h,制得第二粉体;(3) Mix the Xanthium angustifolia, wild chrysanthemum, geese, angelica dahurica, sapsroot, moxa lotus, white peony root, licorice, and tribulus terrestris weighed in step (1), and then grind them with a grinder for 2 hours to obtain the first powder. body, and then pulverize the first powder in an ultrafine pulverizer for 1 hour to obtain a second powder;

(4)在步骤(3)制得的第二粉体中加入4倍其体积的水,搅拌混合,然后加入微波和超声波协同提取罐中进行提取,超声波频率为40KHz,功率为1KW;所述微波频率为1600MHz,功率为2.5KW;所述协同提取温度为65℃,提取时间为2.5h;所得提取液经过滤、滤液采用真空浓缩罐浓缩,控制真空度为0.06Mpa,待提取液浓缩至密度1.30~1.35时,制得稠膏;(4) Add 4 times the volume of water to the second powder prepared in step (3), stir and mix, and then add microwave and ultrasonic waves to a collaborative extraction tank for extraction. The ultrasonic frequency is 40KHz and the power is 1KW; The microwave frequency is 1600MHz, the power is 2.5KW; the collaborative extraction temperature is 65°C, and the extraction time is 2.5h; the obtained extract is filtered, and the filtrate is concentrated using a vacuum concentration tank. The vacuum degree is controlled to 0.06Mpa, and the extract is concentrated to When the density is 1.30~1.35, a thick paste is produced;

(5)将步骤(4)制得的稠膏中加入步骤(2)的胆南星细粉,再加入适量辅料药用淀粉,在槽型混合机中混匀,再放入摇摆式颗粒机过12目筛制湿颗粒,然后放入一步制粒机干燥45分钟,控制温度在60使℃颗粒水分控制在5%以内,停止干燥,倾出,放入摇摆式颗粒机过14目筛整粒,最后将制得的颗粒投入总混设备中,加入步骤(1)称取的马来酸氯苯那敏及适量硬脂酸镁、0.5ml藿香油、0.5ml薄荷油,混匀,经压片,包糖衣,即得鼻舒适片1000片(每片0.2g)。(5) Add the Dannanxing fine powder from step (2) to the thick paste prepared in step (4), then add an appropriate amount of auxiliary medicinal starch, mix in a trough mixer, and then put it into a swing granulator to pass Make wet granules through a 12-mesh sieve, and then put them into a one-step granulator to dry for 45 minutes. Control the temperature at 60°C so that the moisture content of the granules is within 5%. Stop drying, pour out, and put them into a swing granulator through a 14-mesh sieve for granulation. , finally put the prepared granules into the general mixing equipment, add the chlorpheniramine maleate weighed in step (1) and an appropriate amount of magnesium stearate, 0.5ml patchouli oil, 0.5ml peppermint oil, mix well, and press Tablets, sugar-coated, to obtain 1,000 nasal comfort tablets (0.2g each).

临床实验clinical experiments

1.中医诊断标准1. Traditional Chinese Medicine Diagnostic Standards

参照国家中医药管理局发布的中华人民共和国中医药行业标准《中医病证诊断疗效标准》。Refer to the Traditional Chinese Medicine Industry Standard of the People's Republic of China "Standards for the Diagnosis and Efficacy of Traditional Chinese Medicine Diseases and Syndromes" issued by the State Administration of Traditional Chinese Medicine.

2.研究对象2. Research objects

本实验病例选取就诊于耳鼻咽喉科门诊,20-60岁并符合诊断标准的慢性鼻炎患者90例,随机分为3组。This experimental case selected 90 patients with chronic rhinitis who were 20-60 years old and met the diagnostic criteria and visited the otolaryngology clinic, and were randomly divided into 3 groups.

3.研究方法3. Research methods

治疗组1:口服实施例1制得的鼻舒适片,每日3次,一次4片,7天为一疗程,连续服用2个疗程。Treatment group 1: Oral administration of the Nashin Comfort Tablets prepared in Example 1, 3 times a day, 4 tablets at a time, 7 days as a course of treatment, and continuous administration of 2 courses of treatment.

治疗组2:口服实施例2制得的鼻舒适片,每日3次,一次4片,7天为一疗程,连续服用2个疗程。Treatment group 2: Oral administration of the Nashin Comfort Tablets prepared in Example 2, 3 times a day, 4 tablets at a time, 7 days as one course of treatment, and 2 consecutive courses of treatment.

对照组:口服市售新峰药业的鼻舒适片,每日3次,一次4片,7天为一疗程,连续服用2个疗程。Control group: Take commercially available Xinfeng Pharmaceutical Nasal Comfort Tablets orally, 3 times a day, 4 tablets at a time, 7 days as a course of treatment, and take 2 consecutive courses of treatment.

整个治疗过程中不再使用其它治疗药物和方法,在治疗的第1、7、9、12、14天进行观察和评估。结果如表1所示。No other therapeutic drugs and methods will be used during the entire treatment process, and observations and evaluations will be conducted on the 1st, 7th, 9th, 12th, and 14th days of treatment. The results are shown in Table 1.

观察症状:喷嚏、流涕、鼻塞、头痛,鼻甲肿大,粘膜及鼻底分泌物情况,舌象、脉象。Observe symptoms: sneezing, runny nose, nasal congestion, headache, turbinate swelling, mucosal and nasal secretions, tongue and pulse conditions.

临床疗效评定标准Clinical efficacy evaluation standards

(1)治愈:喷嚏、鼻塞、流涕、头痛等症状消失,鼻腔检查正常,评分为0。(1) Cure: Symptoms such as sneezing, nasal congestion, runny nose, headache, etc. disappear, nasal examination is normal, and the score is 0.

(2)显效:主要症状体征显著改善(50~70%),积分降低2/3。(2) Markedly effective: the main symptoms and signs are significantly improved (50-70%), and the points are reduced by 2/3.

(3)有效:喷嚏、鼻塞、流涕、头痛等症状减轻,局部体征明显改善,积分降低1/3。(3) Effective: Symptoms such as sneezing, nasal congestion, runny nose, headache, etc. are alleviated, local physical signs are significantly improved, and the points are reduced by 1/3.

(4)无效:症状和体征无明显改善,积分无改变。(4) Invalid: There is no significant improvement in symptoms and signs, and no change in points.

表1:鼻舒适片的治疗效果Table 1: Therapeutic effects of Nashu Comfort Tablets

从表1可以看出,本发明制备方法制备的鼻舒适片对慢性鼻炎有明显的治疗效果,其疗效显著高于现有市售的鼻舒适片。而且本发明制备方法操作简单,适于质量把控,便于工业化生产,具有较好的应用前景。As can be seen from Table 1, the nasal comfort tablets prepared by the preparation method of the present invention have obvious therapeutic effects on chronic rhinitis, and their therapeutic effects are significantly higher than those of the currently commercially available nasal comfort tablets. Moreover, the preparation method of the present invention is simple to operate, suitable for quality control, convenient for industrial production, and has good application prospects.

显然,上述实施例仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定。本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。Obviously, the above-mentioned embodiments are only examples to clearly illustrate the present invention, but are not intended to limit the implementation of the present invention. Various changes and modifications can be made to the present invention by those skilled in the art without departing from the spirit and scope of the invention. In this way, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and equivalent technologies, the present invention is also intended to include these modifications and variations.

Claims (5)

1. A method of preparing a nasal comfort tablet, the method comprising:
(1) Weighing 364g of fructus xanthil, 145g of wild chrysanthemum, 218g of centipeda minima, 109g of angelica dahurica, 109g of radix sileris, 218g of eclipta alba, 145g of white peony root, 70g of arisaema cum bile, 73g of liquorice, 218g of caltrop and 0.3g of chlorpheniramine maleate for later use;
(2) Crushing the arisaema cum bile weighed in the step (1), and sieving the crushed arisaema cum bile by a 80-100-mesh sieve to obtain arisaema cum bile fine powder;
(3) Mixing the cocklebur fruit, the wild chrysanthemum flower, the centipeda minima, the angelica dahurica, the radix sileris, the eclipta alba, the liquorice and the caltrop which are weighed in the step (1), crushing for 1-2 hours by adopting a crusher to obtain first powder, and then putting the first powder into an ultrafine crusher to crush for 0.5-1 hour to obtain second powder;
(4) Adding water into the second powder prepared in the step (3) for mixing, then adding the mixture into a microwave and ultrasonic synergistic extraction tank for extraction, and filtering and concentrating the extract to obtain thick paste;
(5) Adding the arisaema cum bile fine powder obtained in the step (4) into the thick paste obtained in the step (2), adding a proper amount of auxiliary material medical starch, uniformly mixing, granulating, drying, adding chlorpheniramine maleate and a proper amount of magnesium stearate, patchouli oil and peppermint oil which are weighed in the step (1), uniformly mixing, tabletting, and coating with sugar to obtain the nasal comfort tablet.
2. The method according to claim 1, wherein in the step (4), the volume ratio of the second powder to water is 1:4-6.
3. The method according to claim 1, wherein in the step (4), the ultrasonic frequency is 30-40KHz and the power is 0.8-1KW; the microwave frequency is 1500-1600MHz, and the power is 2-2.5KW; the synergistic extraction temperature is 55-65 ℃; the extraction time is 1.5-2.5h.
4. The method according to claim 1, wherein in the step (4), the concentration is performed in a vacuum concentration tank, and the vacuum degree is controlled to be 0.04-0.06 Mpa during the concentration.
5. The preparation method of claim 1, wherein in the step (5), the arisaema cum bile fine powder of the step (2) is added into the thick paste prepared in the step (4), then a proper amount of auxiliary material medical starch is added, the mixture is uniformly mixed in a groove type mixer, then the mixture is put into a swing type granulator to be wet through a 12-mesh sieve, the mixture is put into a one-step granulator to be dried for 30 to 45 minutes, the temperature is controlled to be 50 to 60 ℃ to ensure that the water content of the particles is controlled to be within 5 percent, the mixture is stopped to be dried, poured out, put into a swing type granulator to be sieved through a 14-mesh sieve for finishing, and finally the prepared particles are put into a total mixing device, and then the chlorpheniramine maleate weighed in the step (1) and a proper amount of magnesium stearate, the sesame oil and the peppermint oil are added, uniformly mixed, pressed into tablets and sugar-coated to obtain the nose comfort tablet.
CN202311682556.9A 2023-12-08 2023-12-08 Preparation method of nose comfort tablet Active CN117599012B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311682556.9A CN117599012B (en) 2023-12-08 2023-12-08 Preparation method of nose comfort tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311682556.9A CN117599012B (en) 2023-12-08 2023-12-08 Preparation method of nose comfort tablet

Publications (2)

Publication Number Publication Date
CN117599012A true CN117599012A (en) 2024-02-27
CN117599012B CN117599012B (en) 2025-03-04

Family

ID=89947996

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311682556.9A Active CN117599012B (en) 2023-12-08 2023-12-08 Preparation method of nose comfort tablet

Country Status (1)

Country Link
CN (1) CN117599012B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030146311A1 (en) * 2001-12-28 2003-08-07 Chin-Hsin Yang Method for producing nanometer micro-powder of natural materials and products of the method
CN102988480A (en) * 2012-10-08 2013-03-27 卞毓平 Method for preparing bile and patchouli rhinitis tablets and application
CN104983967A (en) * 2015-06-18 2015-10-21 南京华宽信息咨询中心 Preparation method and application of nasal comforting tablets
US20180311294A1 (en) * 2015-10-20 2018-11-01 Valbiotis Composition comprising a mixture of molecules extracted from chrysanthellum indicum, cynara scolymus and lycium barbarum and use to act on carbohydrate and/or fat metabolism
CN113940957A (en) * 2021-12-02 2022-01-18 张鹏 Formula for treating rhinitis disease

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030146311A1 (en) * 2001-12-28 2003-08-07 Chin-Hsin Yang Method for producing nanometer micro-powder of natural materials and products of the method
CN102988480A (en) * 2012-10-08 2013-03-27 卞毓平 Method for preparing bile and patchouli rhinitis tablets and application
CN104983967A (en) * 2015-06-18 2015-10-21 南京华宽信息咨询中心 Preparation method and application of nasal comforting tablets
US20180311294A1 (en) * 2015-10-20 2018-11-01 Valbiotis Composition comprising a mixture of molecules extracted from chrysanthellum indicum, cynara scolymus and lycium barbarum and use to act on carbohydrate and/or fat metabolism
CN113940957A (en) * 2021-12-02 2022-01-18 张鹏 Formula for treating rhinitis disease

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
吴正红等主编: "《药剂学》", 30 April 2020, 北京:中国医药科技出版社, pages: 436 - 438 *
周长征等主编: "《全国中医药行业高等教育十四五规划教材 中药制药工程原理与设备 新世纪第5版》", 30 June 2021, 北京:中国中医药出版社, pages: 73 - 75 *
汪河滨等: "甘草黄酮提取方法及抗氧化活性研究", 《时珍国医国药》, vol. 19, no. 9, 20 September 2008 (2008-09-20), pages 2106 - 2107 *
王笃政等: "微波-超声波协同萃取技术在中药有效成分提取中的研究进展", 《化工中间体》, vol. 8, no. 05, 15 May 2011 (2011-05-15), pages 5 - 9 *
黄晓梅等: "野菊花黄色素提取分离研究进展", 《亚太传统医药》, vol. 4, no. 12, 31 December 2008 (2008-12-31), pages 20 - 21 *

Also Published As

Publication number Publication date
CN117599012B (en) 2025-03-04

Similar Documents

Publication Publication Date Title
CN112107609B (en) Application of Jingu lotus preparation in preparing medicine for treating chalazion
CN1899535A (en) Method for preparing dermopathic blood toxic capsule
CN115607644B (en) A traditional Chinese medicine composition for treating IgA nephropathy and its preparation method
CN103142693B (en) Superfine powdery Chinese medicinal preparation for treating allergic rhinitis
CN102416144B (en) Chinese medicine for treating infantile convulsions
CN104189861B (en) A kind of Chinese medicine of facial paralysis
CN117599012A (en) Preparation method of nose comfort tablet
CN103007063B (en) Medicinal composition for treating facial paralysis and preparation method thereof
CN103006780B (en) Traditional Chinese medicinal composition for treating allergic rhinitis and method for preparing same
CN101461873B (en) Chinese patent medicine for treating facial paralysis and preparation method thereof
CN101690791B (en) Traditional Chinese medicine for treating epidemic encephalitis B
CN107095912A (en) A kind of Ultramicro-powder ointment of Repercusion analgesia and preparation method thereof
CN118845922B (en) A patch medicine for treating gouty arthritis and its preparation method and application
CN104491718A (en) Medicine for treating liver-depression and phlegm-stasis type mammary gland hyperplasia and preparation method
CN103340967B (en) Traditional Chinese medicine composition for treating aphtha and preparation method thereof
CN119896714B (en) Soft capsule and preparation method thereof
CN100584364C (en) A blood-activating and tendon-strengthening capsule and its preparation process
CN102846848B (en) A kind of ovulation-stimulating traditional Chinese medicine preparation and its preparation process
CN1954847B (en) Medications for psoriasis
CN1286515C (en) Medicinal composition for treating cyst
CN120754210A (en) Traditional Chinese medicine composition for diminishing inflammation, relieving pain, activating blood and dissolving stasis as well as preparation method and application thereof
CN118453717A (en) Pure traditional Chinese medicine preparation for treating allergic rhinitis and preparation method thereof
CN117771166A (en) Traditional Chinese medicine ointment for treating targeted drug-related rash as well as preparation method and application thereof
CN116270786A (en) Ointment for relaxing muscles and tendons and dredging collaterals and preparation method thereof
CN1094764C (en) Traditional Chinese medicinal powder for treating pharyngolaryngeeal disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant